To download the JPEG format, please click Gallery
LYON, France – February 18, 2016: “2015-2016 period represents a transition phase for the microfluidic single-cell market, announces Yole Développement (Yole). The “More than Moore” market research and strategy consulting company, Yole highlights the emergence of microfluidic technologies, the entry of several new players , the numerous collaborations between industrial companies and the expected releases of new products… all contributing to the impressive growth. According to Yole, the microfluidic market for single-cell isolation tools will more than double in value during the 2015-2016 period, reaching US$ 52.7 million in 2016 (Source: Sample Preparation Automation Through Emerging Microfluidic Technologies Report 2015, Yole Développement, November 2015).
What is the added-value of microfluidic technologies compared to existing technologies? Why have we achieved this level of growth today? What will be the next steps?…
Yole invites you to discover the changing single-cell world and attend Sébastien Clerc’s presentation at Single Molecule & Single Cell Analysis 2016 Conference (March 15 & 16, Madrid, Spain), co-located with the Lab-on-a-chip Europe Conference. Entitled “Microfluidics for Single-Cell Sample Preparation: Market & Technology Analysis”, this talk will take place on March 15 at 2:30 PM. Register right now or contact us for further information!
“Single-cell isolation is a fast-growing field because it enables the identification of small but critical changes from one cell to another within the same population” explains Sébastien Clerc, Technology & Market Analyst from Yole. And he announces: “Microfluidic solutions will follow this growth and capture around 5% of the single-cell market over the next few years”. Behind this success, how is the market is organized? What are the players involved? Yole analyzes…
There are many companies involved in the development of single-cell isolation solutions, confirms the consulting company, Yole. Indeed, Yole’s analysts underline that the market has entered a major turning point with several new players arriving on the market with innovative solutions leading to improved performance and multiplexing capabilities. Yole identified, for example, WaferGen, NanoCellect Biomedical or Sphere Fluidics… that recently or will soon penetrate the single-cell isolation market with disruptive microfluidic technologies. Such companies are supported by strong fundraisings and partnerships.
These new entrants compete with well-established players such as the US-based company Fluidigm, which owns the largest market share for years within single-cell microfluidic market segment. Today the company is still strongly involved in this market and plans to release new solutions in a near future.
Are microfluidic techniques adapted to single-cell isolation? What will be the impact of these technologies on the market? What about cost, performance and feasibility?...
Take the opportunity to learn more about single-cell sample preparation market and technology trends at the Single Molecule & Single Cell Analysis 2016 Conference next month. Yole’s presentation will provide you an overview of single-cell challenges and the benefits of microfluidic technologies. Sébastien Clerc will then propose you an overview of existing solutions along with a dedicated competitive landscape. Sébastien will conclude with the growth scenario based on the potential applications. More information about Yole’s participation, contact us right now.
About Lab-on-a-Chip & Microfluidics, March 15&16, Madrid, Spain:
Drawing in researchers and industry professionals from around the world, this SELECTBIO conference will explore the latest developments in Lab-on-a-Chip devices. This event will cover the key challenges for those working in research, sensor development, device integration, sample preparation, information management, nano engineering or device manufacturing.
Agenda topics include: Analytical Nanotechnologies; Challenges in Microfluidics; Paper Microfluidic Devices; Single Cell Analysis; Technological Barriers for Lab-on-a-chip Devices. The agenda can be viewed on the website.
This conference will be co-located with the Point of Care Diagnostics, and Single Molecule & Single Cell Analysis conferences.
Registered delegates will have unrestricted access to all co-located meetings, and combined exhibition of related service providers. Full program & registration.